Risk factors for early and late morbidity in patients with cardiovascular disease undergoing inguinal hernia repair with a tailored approach: a single-center cohort study

Kamran Hajili, Alberto Vega Hernandez, Jakob Otten, Dana Richards, Claudia Rudroff, Kamran Hajili, Alberto Vega Hernandez, Jakob Otten, Dana Richards, Claudia Rudroff

Abstract

Background: Inguinal hernia repair is a common procedure in surgery. Patients with cardiovascular disease have an increased operative risk for postoperative morbidity. The study aimed to identify the most beneficial surgical procedure for these patients.

Methods: Patients undergoing elective surgery for unilateral or bilateral inguinal hernia between December 2015 and February 2020 were included. The cohort was divided into the group of patients with (CVD group) and without (NO group) cardiovascular disease and analyzed according to the postoperative morbidity distribution and correlated to the surgical technique used.

Results: Of the 474 patients included 223 (47%) were operated on using the Lichtenstein technique and 251 (53%) using TAPP, respectively. In the CVD group the Lichtenstein procedure was more common (n = 102, 68.9%), in the NO group it was TAPP (n = 205, 62.9%; p < 0.001). 13 (8.8%) patients in the CVD group and 12 (3.7%) patients in the NO group developed a postoperative hematoma (p = 0.023). In the further subgroup analysis within the CVD group revealed cumarine treatment as a risk factor for postoperative hematoma development, whereas the laparoscopic approach did not elevate the morbidity risk.

Conclusion: CVD is a known risk factor for perioperative morbidity in general surgery, however, the TAPP method does not elevate the individual perioperative risk.

Keywords: Cardiovascular disease; Inguinal hernia; Lichtenstein procedure; Postoperative morbidity; Postoperative risk factors; TAPP.

Conflict of interest statement

The Authors declare no conflicts of interest. The authors declare that no funds, grants, or other support were received during the preparation of this manuscript. The authors have no relevant financial or non-financial interests to disclose. This manuscript has neither been presented at any conference nor submitted to any other journal for consideration for publication.

© 2023. The Author(s).

References

    1. Köckerling F, Jakob D, Grund S, Schug-Paß C. Prinzipien der minimalinvasiven Chirurgie bei Hernien. Allgemein und Viszeralchirurgie up2date. 2012;6(2):99–115. doi: 10.1055/s-0031-1298350.
    1. Just E, Botet X, Martínez S, Escolà D, Moreno I, Duque E. Reduction of the complication rate in Liechtenstein hernia repair. Int J Surg. 2010;8(6):462–465. doi: 10.1016/j.ijsu.2010.06.006.
    1. Shah S, Marsh H, Khan MS, Shah A, Madaan S. Urological complications of inguinal hernia surgery. Scott Med J. 2013 doi: 10.1177/0036933013482671.
    1. Stechemesser B, Jacob DA, Schug-Paß C, Köckerling F. Herniamed: An Internet-based registry for outcome research in hernia surgery. Hernia. 2012 doi: 10.1007/s10029-012-0908-3.
    1. Böhmer A. The updated ASA classification. Anasthesiol Intensivmed. 2021;62(5):1–10.
    1. Buerke M, Hoffmeister HM. Steuerung der NOAK-Gabe bei invasiven oder operativen Interventionen. Med Klin Intensivmed Notfmed. 2017;112(2):105–110. doi: 10.1007/s00063-016-0240-2.
    1. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 doi: 10.1097/.
    1. Chacko KA. AHA medical/scientific statement. 1994 revisions to classification of functional capacity and objective assessment of patients with diseases of the heart. Circulation. 1995;92(7):2003–2005.
    1. Böhmer A, Defosse J, Geldner G, Rossaint R, Zacharowski K, Zwißler B, et al. The updated ASA classification. Anasthesiologie und Intensivmedizin. 2021;62(5):223–8. doi: 10.19224/ai2021.223.
    1. Turrentine FE, Sohn MW, Jones RS. Congestive heart failure and noncardiac operations: risk of serious morbidity, readmission, reoperation, and mortality. J Am Coll Surg. 2016;222(6):1220–1229. doi: 10.1016/j.jamcollsurg.2016.02.025.
    1. Lee CH, Chiu YT, Cheng CF, Wu JC, Yin WY, Chen JH. Risk factors for contralateral inguinal hernia repair after unilateral inguinal hernia repair in male adult patients: analysis from a nationwide population based cohort study. BMC Surg. 2017;17(1):106. doi: 10.1186/s12893-017-0302-2.
    1. Columbo JA, Lambour AJ, Sundling RA, Chauhan NB, Bessen SY, Linshaw DL, et al. A meta-analysis of the impact of aspirin, clopidogrel, and dual antiplatelet therapy on bleeding complications in noncardiac surgery. Ann Surg. 2018;267(1):1–10. doi: 10.1097/SLA.0000000000002279.
    1. Liedtke JP, Ahrens I. Antithrombozytäre Therapie und Antikoagulation bei Patienten mit koronarer Herzerkrankung. DMW . 2021;146(16):1041–1050. doi: 10.1055/a-1241-6676.
    1. Li J, Wang M, Cheng T. The safe and risk assessment of perioperative antiplatelet and anticoagulation therapy in inguinal hernia repair, a systematic review. Surg Endosc. 2019;33(10):3165–3176. doi: 10.1007/s00464-019-06956-y.
    1. Zeb MH, Pandian TK, el Khatib MM, Naik ND, Chandra A, Morris DS, et al. Risk factors for postoperative hematoma after inguinal hernia repair: an update. J Surg Res. 2016;205(1):33–37. doi: 10.1016/j.jss.2016.06.002.
    1. International guidelines for groin hernia management. Hernia. 2018;22(1):1–165.
    1. Balch JA, Neal D, Crippen C, Johnson-Mann CN, Read TE, Loftus TJ, et al. Safety of laparoscopic inguinal hernia repair in the setting of antithrombotic therapy. Surg Endosc. 2022;36(12):9011–9018. doi: 10.1007/s00464-022-09360-1.
    1. Aiolfi A, Cavalli M, del Ferraro S, Manfredini L, Bonitta G, Bruni PG, et al. Treatment of Inguinal Hernia. Ann Surg. 2021;274(6):954–961. doi: 10.1097/SLA.0000000000004735.
    1. Hill DA, Sleiman M, Castellano MR. Is the perioperative continuation of antiplatelet therapy safe for elective hernia surgery? Am Surg. 2019;85(3):303–305. doi: 10.1177/000313481908500337.
    1. Hada G, Zhang S, Song Y, Jaiswar M, Xie Y, Jian F, et al. Safety of inguinal hernia repair in the elderly with perioperative continuation of antithrombotic therapy. Visc Med. 2021;37(4):315–322. doi: 10.1159/000509895.
    1. Staerkle RF, Hoffmann H, Köckerling F, Adolf D, Bittner R, Kirchhoff P. Does coagulopathy, anticoagulant or antithrombotic therapy matter in incisional hernia repair? Data from the Herniamed Registry. Surg Endosc. 2018;32(9):3881–3889. doi: 10.1007/s00464-018-6127-y.
    1. Köckerling F, Roessing C, Adolf D, Schug-Pass C, Jacob D. Has endoscopic (TEP, TAPP) or open inguinal hernia repair a higher risk of bleeding in patients with coagulopathy or antithrombotic therapy? Data from the Herniamed Registry. Surg Endosc. 2016;30(5):2073–2081. doi: 10.1007/s00464-015-4456-7.
    1. Ho CH, Wu CC, Wu CC, Tsai YC. Laparoscopic total extraperitoneal inguinal hernia repair is safe and feasible in patients with continuation of antithrombotics. J Minim Access Surg. 2019;15(4):299. doi: 10.4103/jmas.JMAS_128_18.
    1. Rudroff C, Schweins M, Heiss M. Die Qualität unseres Abrechnungssystems am Beispiel der Leistenhernien. Zentralbl Chir. 2008;133(1):51–54. doi: 10.1055/s-2008-1004666.
    1. Albrecht M, Manski T, Sander M, Schiffhorst G. Gutachten nach § 115b Abs. 1a SGB V, Internationaler Vergleich ambulanter Operationen, IGES Institut. 2022.
    1. Coughlin JW, Martin LM, Zhao D, Goheer A, Woolf TB, Holzhauer K, et al. Electronic Health Record-Based Recruitment and Retention and Mobile Health App Usage: Multisite Cohort Study. J Med Internet Res. 2022;24(6):e34191. doi: 10.2196/34191.
    1. Anhang Price R, Quigley DD, Hargraves JL, Sorra J, Becerra-Ornelas AU, Hays RD, et al. A systematic review of strategies to enhance response rates and representativeness of patient experience surveys. Med Care. 2022;60(12):910–918. doi: 10.1097/MLR.0000000000001784.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe